<DOC>
	<DOCNO>NCT00188214</DOCNO>
	<brief_summary>Cancer lung treat surgery , radiation chemotherapy , depend stage extent disease . Some patient treat chemotherapy and/or radiation therapy surgery improve result surgery . After treatment , know whether residual tumour tissue still alive dead , physician feel surgery require remove . This study design assess compute tomography ( CT , CAT-scan ) enhance intravenous contrast agent ( dye ) characterize lung cancer , say whether alive dead . The researcher hope future contrast-enhanced CAT-scan make surgery less often necessary improve result chemotherapy and/or radiation give surgery .</brief_summary>
	<brief_title>CT Perfusion Scans Assessment Lung Cancer Before After Chemo +/- Radiotherapy</brief_title>
	<detailed_description>The propose study perform patient proven lung cancer induction therapy subsequent surgical resection kind plan . Kinetic analysis dynamic contrast-enhanced CT perform use CT Perfusion 3 software ( General Electric Medical Systems ) , yield parameter characterize tumor microvasculature term vascularity , blood volume ( BV ) , tumor perfusion blood flow ( BF ) , immaturity vascular wall , term microvascular permeability ( permeability surface area , PS ) . To test assumption dynamic CT-assessed tumor microvascular characteristic represent reliable , user-independent reproducible parameter , microvascular value parameter map derive two independent observer . To address interobserver variability , study analyzed PI second researcher ( blinded result PI ) . Kappa-statistics used assess inter-rater concordance . To test hypothesis microvascular parameter obtain dynamic contrast-enhanced CT predict response induction therapy , parameter BV , BF PS obtain prior treatment correlate histological result resect specimen ( path CR path non-CR ) . Spearman correlation use compare non-parametric histology result quantitative CT microvascular parameter . To test hypothesis microvascular parameter obtain dynamic contrast-enhanced CT reflect response induction therapy , parameter BV , BF PS obtain completion induction treatment correlate histological result resect specimen ( path CR path non-CR ) . Spearman correlation use compare non-parametric histology result quantitative CT microvascular parameter .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>diagnosis nonsmall cell lung cancer Patients schedule neoadjuvant treatment Females know pregnant nursing Patients history adverse reaction previous contrast agent administration Patients know renal disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>perfusion</keyword>
	<keyword>CT</keyword>
	<keyword>CAT</keyword>
	<keyword>non-small</keyword>
	<keyword>lung</keyword>
</DOC>